Allurion Technologies, Inc. (ALUR): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$983.0K

Year ended 2025-12-31

$951.0K

Trailing 12 months to 2026-03-31

+3.2%

3-year compound annual growth

2022-12-31 Depreciation & Amortization (USD) 2025-12-31

Period ended	Depreciation & Amortization	Change YoY	Source filing
2025-12-31	$983.0K	-1.4%	2026-03-30, From 2025-01-01
2024-12-31	$997.0K	+33.6%	2026-03-30, From 2024-01-01
2023-12-31	$746.0K	-16.6%	2025-08-28, From 2023-01-01
2022-12-31	$895.0K	n/a	2025-08-28, From 2022-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Depreciation & Amortization	Change YoY
Allurion Technologies, Inc. (ALUR)	2025-12-31	$983.0K	-1.4%
Vivos Therapeutics, Inc. (VVOS)	2025-12-31	$1.31M	+125.3%
Nephros Inc (NEPH)	2025-12-31	$140.0K	+3.7%
Sonoma Pharmaceuticals, Inc. (SNOA)	2026-03-31	$139.0K	+0.7%
Nexgel, Inc. (NXGL)	2025-12-31	$450.0K	+3.2%
Baird Medical Investment Holdings Ltd (BDMD)	2025-12-31	$1.10M	-3.1%
WORK Medical Technology Group LTD (WOK)	2025-09-30	$923.1K	-34.6%
Medinotec Inc. (MDNC)	2026-02-28	$80.9K	+9.5%
Neuroone Medical Technologies Corp (NMTC)	2025-09-30	$261.7K	+6.0%

Compare ALUR, VVOS, NEPH, SNOA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗